本文就如何通过加速发展ANDA(仿制药)来降低药费进行分析。美国虽然药品研发能力很强,但仍然是全球最大的仿制药市场,据IMS统计,2013年全球仿制药市场规模达1600亿美元,其中美国为500亿美元。中国现存的17万个药品批文绝大多数是仿制药,中国仿制药市场规模接近5000亿元。
<<The author of this report,Dr.Zhang Ziran analyzed how to lower drug prices through accelerating the development of ANDA.While the U.S.has great capacity for the R&D of drugs,it's still the biggest market of generic drugs in the world.According to the statistics of IMS,the global market of generic drugs had a scale of USD 160 trillion,in which the U.S.accounted for USD 50 trillion.Most of the currently marketed drugs(170000 drug approvals) in China are generic drugs,and China's market of generic drugs has a scale of nearly RMB 500 trillion.
<<